Don’t miss OpenAI, Chevron, Nvidia, Kaiser Permanente, and Capital One leaders solely at VentureBeat Rework 2024. Acquire important insights about GenAI and increase your community at this unique three day occasion. Study Extra
Endiatx’s swallowable robotic tablet hits medical trials, firm preps for FDA assessment and industrial launch
In a improvement straight out of science fiction, Endiatx, a pioneering medical know-how firm, is making vital strides in bringing its robotic tablet to market. The corporate’s CEO, Torrey Smith, not too long ago sat down with VentureBeat to share thrilling updates on their progress, practically two years after our preliminary protection of the startup’s bold imaginative and prescient.
Based in 2019, Endiatx has been steadily working in the direction of realizing the improbable voyage of miniaturized robots navigating the human physique for diagnostic and therapeutic functions. Their flagship product, the PillBot, is an ingestible robotic capsule outfitted with cameras, sensors, and wi-fi communication capabilities, permitting medical doctors to look at the gastrointestinal tract with unprecedented precision and management.
Within the interview, Smith revealed that Endiatx has raised $7 million in funding to this point, with the most important funding of $1.5 million coming from Singapore-based Verge Well being Tech Fund. This injection of capital has propelled the corporate ahead, enabling them to refine their know-how and conduct medical trials.
Countdown to VB Rework 2024
Be a part of enterprise leaders in San Francisco from July 9 to 11 for our flagship AI occasion. Join with friends, discover the alternatives and challenges of Generative AI, and discover ways to combine AI purposes into your business. Register Now
“We’re currently in clinical trials with our pill bot technology,” Smith defined. “We’ll be starting pivotal trials at a leading U.S. medical institution in Q3/Q4.” Although Smith didn’t title the establishment resulting from confidentiality agreements, he hinted that it’s a famend facility recognized for its experience in gastroenterology.
The PillBot has come a great distance since its inception. The present prototype measures simply 13mm by 30mm and boasts spectacular capabilities. “It can transmit high-res video at 2.3 megapixels per second, and we have plans to quadruple that video quality soon,” Smith enthused. The CEO himself has performed an important function in testing, having swallowed 43 PillBots to this point, together with dwell on stage in entrance of a surprised viewers.
Endiatx’s final objective is to safe FDA approval and launch commercially within the U.S. by early 2026. The corporate envisions a future the place PillBots are available and inexpensive, probably even bought over-the-counter at pharmacies for round $50. This might completely rework the sphere of gastroenterology, making diagnostic procedures extra accessible, handy, and cost-effective for sufferers.
However Smith’s imaginative and prescient extends far past simply making the PillBot broadly out there. He sees synthetic intelligence (AI) taking part in an important function within the machine’s future. “AI is how we go from 1 percent of people getting access to this tech to 100 percent of people getting access to it multiple times a year if necessary,” he defined.
Presently, the PillBot requires a physician to manually management its motion and digital camera, however Smith envisions a future the place the machine is totally autonomous, guided by AI. This might enable the know-how to succeed in a fair wider inhabitants, probably saving numerous lives via early detection and therapy of gastrointestinal points.
Smith emphasised that AI fashions require huge quantities of information to study and enhance, and that’s the place Endiatx’s PillBot is available in. “PillBot is the fountain of cheap data inside the human body,” he mentioned. “The data services that we intend to offer as part of this ecosystem are going to completely change the way that we do healthcare.”
How PillBot works: A tiny robotic marvel
On the coronary heart of Endiatx’s groundbreaking know-how is the PillBot, a miniature robotic capsule that packs a robust punch. Measuring simply 13mm by 30mm, this tiny machine is designed to be simply swallowed by sufferers, permitting it to navigate via the gastrointestinal tract and supply medical doctors with detailed imagery of the physique’s inside workings.
The PillBot is supplied with a state-of-the-art digital camera system, able to capturing high-resolution video at a powerful 2.3 megapixels per second. This video feed is transmitted wirelessly to a physician’s pc or cell machine in real-time, offering a dwell, up-close take a look at the affected person’s digestive system.
What units the PillBot aside from conventional endoscopy is its non-invasive nature and ease of use. In contrast to typical endoscopy procedures, which require sedation and a go to to a medical facility, the PillBot may very well be swallowed by the affected person within the consolation of their very own house. This coud finally get rid of the necessity for expensive and time-consuming hospital visits, making the diagnostic course of extra handy and accessible for sufferers.
However the PillBot isn’t only a easy tablet digital camera. It’s a fully-fledged robotic machine, full with its personal propulsion system. Tiny micromotors and propellers enable the PillBot to maneuver via the intestine with precision and management, guided by a physician utilizing a easy handheld sport controller.
“The front of PillBot is basically like a normal pill camera,” Smith defined. “It’s got LEDs to illuminate, it has a nice camera, it has electronic communication with the outside world. The back of PillBot is three DC electric motors with propellers on them, oriented so that you can fly in X, Y, and Z.”
This degree of maneuverability is what distinguishes the PillBot from different swallowable tablet cameras in the marketplace. Whereas most tablet cameras depend on pure intestine actions to navigate via the digestive tract, the PillBot may be actively managed, permitting medical doctors to look at particular areas of curiosity in higher element.
Powering this miniature marvel is a tiny battery, which gives sufficient power for the PillBot to finish its mission and transmit helpful knowledge again to the physician. And due to Endiatx’s superior engineering, all of those elements are safely encapsulated inside a biocompatible shell, guaranteeing that the machine is each efficient and protected for sufferers to ingest.
From the second it’s swallowed to the time it’s naturally expelled from the physique, the PillBot is consistently working, gathering important data that may assist medical doctors diagnose and deal with a variety of gastrointestinal problems. It’s a testomony to the ability of miniaturization and the ingenuity of the Endiatx crew, who’ve managed to pack such superior know-how into a tool no bigger than a multivitamin.
The journey from idea to actuality for Endiatx’s PillBot has been one in all relentless innovation and problem-solving. When the corporate first got down to create a swallowable robotic tablet, they knew they had been dealing with a frightening job. The earliest prototypes had been removed from the smooth, compact machine that exists right this moment.
“We started at football size,” Smith revealed, chuckling on the reminiscence. “We’ve just gone through over 20 different generations to make it smaller and smaller.”
Shrinking a posh robotic system right down to a dimension that may very well be simply swallowed was no small feat. The Endiatx crew needed to discover methods to miniaturize each element, from the cameras and motors to the batteries and wi-fi communication modules. This required a deep understanding of engineering rules and a willingness to assume outdoors the field.
One of many greatest challenges was discovering a approach to transmit high-quality video from contained in the physique with out utilizing an excessive amount of energy. The crew experimented with varied wi-fi applied sciences earlier than selecting a custom-designed system that might present dependable, high-speed knowledge transmission whereas minimizing power consumption.
“We have to push a radio signal through salty human tissue, which is really hard,” Smith defined. “We are down in the low band, at 915 megahertz right now.”
One other vital hurdle was making a propulsion system that might successfully navigate the advanced surroundings of the human intestine. The crew examined quite a few designs, from quad-copter configurations to the present tri-motor setup, earlier than discovering a steadiness between energy, management, and dimension.
However maybe probably the most spectacular side of the PillBot’s evolution is the best way through which Endiatx has managed to pack all of those superior applied sciences into such a tiny package deal. The present prototype, measuring simply 13mm by 30mm, is a marvel of miniaturization.
“Right now, it’s a treat,” Smith mentioned, holding up the machine. “13 millimeters by 30. But if you hold a handful of pill cameras in your hand, it just looks and feels like a bunch of normal pills.”
This achievement is a testomony to the talent and dedication of the Endiatx engineering crew. By leveraging cutting-edge manufacturing strategies, comparable to 3D printing and {custom} versatile circuit boards, they’ve been in a position to create a tool that’s not solely small and swallowable but in addition sturdy sufficient to face up to the cruel surroundings of the human digestive system.
Reviving the spirit of Silicon Valley innovation
In a tech panorama now dominated by software program and apps, Endiatx stands out as a throwback to the early days of Silicon Valley innovation. The corporate’s strategy to creating the PillBot hearkens again to a time when engineers, consultants, and tinkerers labored side-by-side to resolve advanced issues with cutting-edge know-how.
Based in a storage in Redwood Metropolis, California, Endiatx embodies the spirit of the idealized Silicon Valley startup. “We started in my living room,” recalled Smith. “It’s like a hardcore group of deep tech engineers. We build it here. We code it here. We swallow it here.” That quote ought to go on the wall someplace.
This hands-on, vertically built-in strategy is central to Endiatx’s means to innovate shortly and push the boundaries of what’s potential with medical robotics. In contrast to many trendy tech firms that rely closely on outsourcing and off-the-shelf elements, Endiatx has chosen to maintain each side of the PillBot’s improvement in-house.
“We are completely vertically integrated,” Smith defined. “We write all the code. We have to pack all of the compute, storage, processing, and radio into an extremely small form factor with very limited electrical power. There’s no room on this system anywhere to use someone else’s software libraries.”
By designing and manufacturing every little thing themselves, the Endiatx crew can make sure that every element of the PillBot is optimized for the particular challenges of working contained in the human physique. This degree of management and customization is crucial when working at such a small scale, the place each millimeter and milliamp issues.
However vertical integration isn’t nearly technical necessity, as a result of it’s additionally about fostering a tradition of collaboration and problem-solving. The Endiatx crew contains a various group of consultants, together with engineers, software program builders, and medical professionals, who work side-by-side to deal with challenges from each angle.
“If you just showed up randomly, you’d probably shake hands with 15 engineers, 15 people that are physically here grinding out full-time work,” Smith famous.
This multidisciplinary strategy permits for a degree of creativity and cross-pollination that is likely to be misplaced in a bigger and extra siloed group. By working collectively below one roof, the crew can shortly iterate on designs, check prototypes, and refine the PillBot’s capabilities in real-time.
Strolling via the Endiatx headquarters in Hayward, California, the spirit of innovation is palpable. The area is a hive of exercise, with areas devoted to engineering, manufacturing, and testing. “We’ve got an office area, but then we also have injection molding, mills, lathes, we’ve got welding, sandblasting, and then the 3D printing and all the electronics design and precision assembly,” Smith described as he took us on a digital tour.
This state-of-the-art facility permits Endiatx to maneuver from idea to prototype to closing product at a tempo that may be unattainable in the event that they had been counting on exterior companions. It’s a throwback to the early days of Silicon Valley, when firms like Hewlett-Packard and Apple had been born in garages and grew into world powerhouses on the power of their engineering prowess and progressive spirit.
In a Silicon Valley that usually appears extra centered on incremental positive factors and fast exits than on really groundbreaking innovation, Endiatx stands as a reminder of what’s potential when a bunch of devoted engineers and problem-solvers come collectively to deal with a serious problem. Their vertically built-in, garage-startup strategy could also be a throwback, but it surely’s additionally a mannequin for a brand new era of deep tech innovators trying to make an actual distinction on the planet.
The lengthy shadow of Theranos and Silicon Valley’s misplaced priorities
The story of Endiatx’s wrestle for funding is a cautionary story that highlights each the lengthy shadow forged by the Theranos scandal and the misplaced priorities of Silicon Valley traders. Whereas the corporate’s groundbreaking robotic tablet know-how has the potential to completely rework healthcare, Endiatx has needed to navigate a difficult panorama formed by skepticism and shortsightedness.
The high-profile downfall of Elizabeth Holmes and her blood-testing startup, Theranos, has made traders and the general public cautious of daring claims within the medical know-how business. For Smith, the affect of this scandal has been each irritating and motivating. “I’m sort of upset that they were able to raise more than a billion dollars on lies,” he confessed. “And we’ve raised 7 million telling the truth.”
This skepticism has made it tougher for reliable startups like Endiatx to safe funding and belief from traders, significantly in Silicon Valley. “I’ve pitched this company more than a thousand times all over the world,” Smith mentioned. “A lot of the investors, especially in biotech and deep tech investors, were like, ‘Hey, I’m not going to get fooled again by this nonsense.’”
However the Theranos debacle is only one half of a bigger downside plaguing Silicon Valley’s funding tradition. In recent times, the area’s traders have grow to be more and more centered on short-term positive factors and fast exits, pouring billions of {dollars} into apps and platforms that supply incremental enhancements to present companies, quite than tackling really exhausting issues.
From yet one more meals supply startup promising barely sooner service to the newest crypto scheme, Silicon Valley’s priorities appear to have strayed removed from the sort of deep, significant innovation that firms like Endiatx characterize. This shortsightedness not solely denies funding to probably world-changing applied sciences but in addition dangers eroding the Bay Space’s repute as a hub for groundbreaking innovation.
Confronted with this difficult panorama, Endiatx has needed to work tougher to show the legitimacy and viability of its know-how. The corporate has prioritized transparency, overtly discussing the technical hurdles they’ve confronted, the rigorous testing and medical trials they’ve undergone, and the regulatory approvals they’ve secured.
“We’d say, ‘Fine, we will swallow this camera live on, or this pill, this robot pill, live on stage, and we will put the live video up on the big screen, and I will give you the Xbox controller,’” Smith recounted. “‘And you know, as far as I’m involved, you’ll be able to race it round my abdomen. We have to present those that we’re really doing it.’”
This dedication to tangible proof has been essential in serving to Endiatx construct belief and credibility within the wake of Theranos. Nevertheless it has additionally meant wanting past the confines of Silicon Valley for funding. Regardless of the corporate’s ties to the Bay Space, it was a agency from Singapore, Verge HealthTech Fund, that stepped as much as lead their $1.5 million Sequence A spherical.
The truth that Endiatx needed to look past Silicon Valley for its most important backing is a pertinent instance of simply how far the area’s funding priorities have drifted. It means that even within the coronary heart of the tech world, there’s a rising disconnect between what traders are funding and what really issues when it comes to societal affect and human progress.
However for Smith and his crew, the Theranos scandal and Silicon Valley’s skepticism have additionally served as a robust motivator. They’re pushed by a need to show that actual innovation and progress are potential within the medical know-how area, and that not each startup with a daring imaginative and prescient is destined to comply with in Holmes’ footsteps.
AI, autonomy, and the transformative potential of robotic drugs
For Endiatx, the journey to convey the PillBot to market is only the start of a a lot bigger imaginative and prescient for the way forward for medical robotics. Smith has his sights set on an much more bold objective: creating AI-powered, autonomous robotic drugs that may navigate your complete human physique and carry out surgical procedures.
“I think we’re creating a trillion-dollar market category with tiny robots in the body,” Smith defined. “I think it’s going to completely change the way we do internal medicine.”
Central to this imaginative and prescient is the mixing of synthetic intelligence into the PillBot platform. Smith believes that AI would be the key to creating the know-how accessible to everybody, not simply the fortunate few who can afford cutting-edge medical care.
By gathering huge quantities of information from contained in the physique and utilizing it to coach AI algorithms, Endiatx goals to create robotic drugs that may autonomously navigate the advanced terrain of the human anatomy, detecting and diagnosing points with out the necessity for fixed human oversight. This might dramatically cut back the price and improve the accessibility of superior medical diagnostics, making it potential for folks all over the world to learn from the know-how.
However Smith’s ambitions don’t cease at prognosis. He envisions a future the place robotic drugs can carry out focused surgical procedures, delivering therapies on to the positioning of illness or harm. “Honestly, I’m not going to be creatively satisfied until we put surgical tools on PillBot, until we’ve made PillBot small enough that it can go other places in your body,” he declared.
This imaginative and prescient of miniaturized, autonomous surgical robots might sound like science fiction, however Smith is assured that it’s an achievable objective. “I want to make rice grain size, nuclear powered, brain surgeons, right, that can go after those glioblastomas” he mentioned, referring to the non-public tragedy of his aunt’s terminal mind tumor that impressed him to pursue a profession in medical robotics.
This devoted crew of engineers and researchers is consistently innovating, discovering methods to shrink the PillBot’s elements and improve its capabilities. From {custom} versatile circuit boards to superior battery applied sciences, each side of the machine is being optimized for the challenges of working contained in the human physique.
As Endiatx continues to make strides in the direction of this bold future, the potential affect on healthcare is actually staggering. Think about a world the place most cancers may be detected and handled earlier than signs even seem, the place life-saving surgical procedures may be carried out with out a single incision, and the place probably the most superior medical care is accessible to everybody, no matter their location or financial standing.
That is the longer term that Torrey Smith and the crew at Endiatx are working in the direction of – a future through which the ability of robotics, AI, and miniaturization is harnessed to revolutionize the best way we strategy human well being and well-being. It’s a daring imaginative and prescient, however one that’s grounded within the very actual progress the corporate has already made with the PillBot.
A brand new wave of deep tech innovation
As Endiatx continues to push the boundaries of medical know-how, it’s clear that we’re witnessing extra than simply the rise of one other promising startup. The PillBot represents the start of a protracted wave of deep tech innovation, a return to the core values that after made Silicon Valley the world’s most vibrant and transformative know-how hub.
In an period when many traders and entrepreneurs have grow to be extra centered on fast wins and incremental positive factors, Endiatx stands as a reminder of the unimaginable energy of tackling exhausting issues with cutting-edge science and engineering. However past its groundbreaking know-how, the corporate additionally serves as a mannequin for innovate successfully in right this moment’s advanced and rapidly-evolving enterprise panorama.
Endiatx’s success is a testomony to the ability of breaking down obstacles, fostering shut collaboration, and embracing vertical integration. By bringing collectively consultants from various fields – from robotics and AI to drugs and supplies science – and conserving each side of improvement in-house, the corporate has been in a position to transfer with unparalleled velocity and agility.
This strategy has allowed Endiatx to beat the numerous technical and regulatory hurdles that usually decelerate or derail bold deep tech tasks. By proudly owning each a part of the method, from preliminary analysis to closing manufacturing, the corporate has been in a position to preserve a laser deal with its final objective, even because it navigates the complexities of creating a first-of-its-kind medical machine.
On this sense, Endiatx’s story carries essential classes not only for different deep tech startups, however for any group trying to drive transformative innovation within the face of daunting challenges. Whether or not you’re a Fortune 500 firm trying to pivot into new markets or a scrappy startup attempting to convey a daring imaginative and prescient to life, the rules which have guided Endiatx’s journey – collaboration, integration, and a relentless dedication to pushing boundaries – are extra related than ever.
In fact, not each firm can or ought to aspire to the sort of vertical integration that Endiatx has achieved. However the underlying philosophy – that true innovation requires breaking down silos, bringing collectively various views, and proudly owning your complete downside – is one which decision-makers throughout industries would do properly to embrace.
As we stand on the cusp of a brand new period of technological transformation, pushed by advances in fields like robotics, AI, and biotech, this philosophy will solely grow to be extra essential. The challenges we face, from curing illnesses to mitigating local weather change to extending human presence past Earth, would require a degree of ambition, collaboration, and outside-the-box considering that few firms have but to realize.
But when the story of Endiatx tells us something, it’s that this sort of transformative innovation is feasible – and that the rewards for individuals who pursue it are immense. Not simply when it comes to enterprise success, however when it comes to the affect they will have on the world.
Because the PillBot begins its journey from the lab to the clinic to the broader world, it carries with it the promise of a brand new period of healthcare, one the place early illness detection and minimally invasive therapies are accessible to all. Nevertheless it additionally carries the promise of one thing larger – a brand new mannequin for innovation itself, one that’s pushed by daring visions, enabled by cross-disciplinary collaboration, and realized via a fearless dedication to tackling the toughest issues.
For know-how decision-makers throughout industries, that is the lesson to take from Endiatx’s exceptional journey. That in an age of fast change and daunting challenges, the important thing to success lies not simply in what you innovate, however in the way you innovate. And that by breaking down obstacles, considering past incrementalism, and embracing the sort of end-to-end possession that Endiatx embodies, even probably the most audacious visions can grow to be actuality.
That is the spirit of deep tech innovation, the spirit of a reborn Silicon Valley – and it’s a spirit that we’ll want greater than ever as we navigate the challenges and alternatives of the a long time forward. Endiatx is displaying us the best way ahead, one tiny robotic at a time. The query now’s who will comply with of their footsteps, and the way far will they go?